欧美午夜精品久久久久免费视-亚洲国产精品无码久久久-鲁鲁狠狠狠7777一区二区-特黄aaaaaaa片免费视频

Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one, also known as Glycerol, is a reagent used in organic synthesis, particularly for the introduction of the non-chiral (oxodioxolenyl)methyl carbamate group to active pharmaceutical ingredients (APIs) to afford the corresponding pro-drug.
Used in Pharmaceutical Industry:
4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one is used as a reagent for the introduction of the non-chiral (oxodioxolenyl)methyl carbamate group to active pharmaceutical ingredients (APIs) for the development of pro-drugs.
Used in Preparation Method of Key Intermediate of Olmesartan Medoxomil:
4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one is used as a reagent in the preparation method of key intermediate of olmesartan medoxomil, a medication used to treat high blood pressure.

91526-18-0

Post Buying Request

91526-18-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

91526-18-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 91526-18-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,5,2 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 91526-18:
(7*9)+(6*1)+(5*5)+(4*2)+(3*6)+(2*1)+(1*8)=130
130 % 10 = 0
So 91526-18-0 is a valid CAS Registry Number.

91526-18-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one

1.2 Other means of identification

Product number -
Other names 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:91526-18-0 SDS

91526-18-0Relevant articles and documents

MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF

-

Paragraph 0297-0300, (2021/06/22)

The invention relates to a monoethylenically unsaturated monomer of formula (I), and to the use thereof for producing a polymer. The invention also relates to the polymer obtained by polymerising said monomer, and to the use thereof in a composition for producing coatings.

AN IMPROVED PROCESS FOR 4-(HYDROXYMETHYL)-5-METHYL-1,3-DIOXOL-2-ONE

-

Page/Page column 5; 7-8, (2021/04/17)

The present invention relates to an improved process for 4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one (I). The process involves reaction of compound of formula (II) with sodium acetate in presence of catalytic amount of potassium iodide in dimethyl formamide solvent at 25-30°C to give 5-methyl-2-oxo-1,3-dioxol-4-yl)methyl acetate (IV) which was further Acid hydrolysed by IPA. HCl in Isopropyl alcohol solvent to yield 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one (I).

Preparation method of olmesartan medoxomil key intermediate

-

Paragraph 0026-0034, (2021/08/07)

The invention discloses a preparation method of an olmesartan medoxomil key intermediate, and belongs to the technical field of medicine synthesis. The key points of the technical scheme are as follows: triphosgene with relatively low toxicity is adopted to replace gaseous phosgene, so that the problems of storage and transportation are solved; and a molecular distillation technology is utilized to treat the crude product, so that the occurrence of a polymer at high temperature is avoided, and a high-yield product is obtained.

Method for synthesizing 4 - (hydroxymethyl) -5 - methyl-[1, 3] dioxole -2 - ketone (by machine translation)

-

Paragraph 0009; 0022-0042, (2020/09/20)

The invention discloses a method for synthesizing 4 - (hydroxymethyl) -5 - methyl-[1, 3] dioxole -2 - ketone, and belongs to the technical field of chemical synthesis. The reaction equation in the synthesis process is as follows. By selecting proper solvent and hydrolysis medium and optimizing the dosage ratio between reactants, the reaction rate and yield are greatly improved, the reaction is more complete and thorough, the yield of the target product reaches 92%, and the purity of the target product reaches 97%. (by machine translation)

Tetrahydrocyclopentapyrrole derivative and preparation method therefor

-

Paragraph 0741; 0742; 0743; 0744, (2016/10/08)

The purpose of the present invention is to provide: a tetrahydrocyclopentapyrrole derivative capable of being used for preventing or treating a peptic ulcer gastritis or reflux esophagitis; a preparation method therefor; and a pharmaceutical composition containing the same.

Cyclic amine derivative and pharmaceutical use thereof

-

Paragraph 0323, (2016/10/09)

The purpose of the present invention is to provide a compound that exerts a strong analgesic action against on pain, in particular, against neuropathic pain and/or fibromyalgia syndrome. The present invention provides a cyclic amine derivative represented by chemical formula, a prodrug thereof or a pharmaceutically acceptable salt thereof.

CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF

-

Paragraph 0413; 0414, (2016/08/07)

A compound exerts a strong analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. The cyclic amine derivative is represented by formula, a prodrug thereof or a pharmacologically acceptable salt thereof: wherein A represents a group represented by Formula (IIa), (IIb) or (IIc): wherein R3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, R4 represents a hydrogen atom or an alkylcarbonyl group having 2 to 6 carbon atoms or an alkyl group having 1 to 6 carbon atoms and optionally substituted with an alkylcarbonylamino group having 2 to 6 carbon atoms and n represents 1 or 2, in which when R3 and R4 each independently represent an alkyl group having 1 to 6 carbon atoms, R1 represents an alkyl group having 1 to 6 carbon atoms and substituted with a hydroxyl group, an amino group or a carboxyl group.

AN IMPROVED PROCESS FOR THE PREPARATION OF AZILSARTAN MEDOXOMIL

-

Page/Page column 14-15, (2012/08/28)

The present invention relates to an improved process for the preparation of azilsartan or its esters or salts thereof. Specifically, the invention provides a method for the preparation of highly pure methyl 1-[[2,-(4,5-dihydro-5-oxo-4H-1,2,4-oxadiazol-3- yl)biphenyl-4-yl]methyl]-2-ethoxy-1H-benzimidazo!e-7 -carboxylate an intermediate compound of formula (4) for azilsartan medoxomil with reduced content of dcsethyl impurity. The invention also involves the use of highly pure methyl 1-[[2'-(4,5-dihydro- 5-oxo-4H-1,2,4-oxadiazol-3-yl) biphenyl-4-yl] methyl]-2-ethoxy-1H-benzirnidazole-7- carboxylate in the preparation of azilsartan or its esters or salts thereof, preferably medoxomil with reduced content of desethyl impurity.

N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE

-

Page/Page column 159, (2012/05/20)

The present invention provides a compound of formula (I): wherein R1a is optionally substituted C1-6 alkyl, etc.; R1m is hydrogen atom, etc.; G1, G2, G3 and G4 are (i), etc. ((i) G1 is -N(R1b)-, G2 is -CO-, G3 is -C(R1c)(R1d)-, and G4 is oxygen, etc.); R1b is optionally substituted C1-6 alkyl, etc.; R1c and R1d are each independently optionally substituted C1-6 alkyl, etc.; R2 is optionally substituted C1-6 alkyl, etc.; R3a, R3b, R3c, and R3d are each independently a group: -A-B (A is a single bond, etc., B is hydrogen atom, etc.), etc.; n is 1, etc.; R5 is C1-4 alkoxycarbonyl, etc., or a pharmaceutically acceptable salt thereof, which is useful as a renin inhibitor.

Prodrugs of GABA analogs, compositions and uses thereof

-

Page/Page column 45, (2010/11/24)

The present invention provides prodrugs of GABA analogs, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs. The present invention also provides methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 91526-18-0